Rici Healthcare Holdings Announces Significant Share Repurchase Plan up to HK\$100 Million
Key Points for Investors
- Share Repurchase Mandate: The Board of Rici Healthcare Holdings Limited has been granted a general mandate to repurchase up to 10% of its issued shares, excluding any treasury shares, as approved at the 2025 Annual General Meeting.
- Repurchase Amount: The total share repurchase amount will not exceed HK\$100 million, funded entirely from the Company’s own resources, excluding proceeds from its Main Board listing.
- Repurchase Period: The repurchase period will start from the Board’s approval date and end at the conclusion of the next annual general meeting in 2026.
- Treasury Shares: Repurchased shares will be held as treasury shares. These may be cancelled, sold, or transferred in the future, including for potential use in equity incentive schemes.
Details of the Share Repurchase and Strategic Rationale
The Board has thoroughly evaluated the Company’s operational stability, financial sustainability, and future growth outlook. The Directors believe the market capitalisation of Rici Healthcare shares is currently undervalued relative to the intrinsic value of the business. The share repurchase initiative aims to safeguard Company value, protect shareholder interests, and reinforce management’s confidence in the Company’s long-term prospects.
The repurchase is seen as a strong signal to the market, reflecting management’s high conviction in the Company’s future. By potentially reducing the total shares outstanding, the Company seeks to boost value recognition and deliver stable, long-term returns to shareholders. This move is positioned as being in the best interests of both the Company and all shareholders.
Regulatory Compliance and Public Float
- The repurchase will be carried out in full compliance with the Company’s Articles of Association, Hong Kong Listing Rules, Codes on Takeovers and Mergers and Share Buy-backs, and all relevant laws.
- The Company confirms the repurchase will not cause public shareholding to fall below the minimum public float requirement under the Listing Rules.
Potential Market Impact and Shareholder Guidance
- Price Sensitivity: Share repurchase programs are often viewed by markets as positive signals, suggesting management’s confidence in future performance and potentially supporting share price appreciation.
- No Fixed Plan: The Company notes that the timing, quantity, and price of share repurchases are not fixed and remain at the Board’s sole discretion, subject to prevailing market conditions.
- Investor Guidance: Shareholders and prospective investors are advised to exercise caution when dealing in the Company’s securities due to the discretionary nature of the repurchase plan and its potential impact on share price.
Board Composition
The current Board consists of four executive Directors (Dr. Fang Yixin, Dr. Mei Hong, Mr. Fang Haoze, Ms. Lin Xiaoying) and three independent non-executive Directors (Mr. Jiang Peixing, Ms. Wong Sze Wing, Mr. Tian Wenguo).
Conclusion
The proposed share repurchase by Rici Healthcare Holdings represents a notable corporate action that may impact share price and is intended to enhance shareholder value. Investors should monitor further announcements for details on execution and its effects on market dynamics.
Disclaimer
This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult professional advisers before making any investment decisions. The Company’s share repurchase is subject to market conditions and regulatory compliance; the timing, quantity, and price of repurchases may vary depending on Board discretion.
